Norris Medicines Appoints New MD
Norris Medicines Limited concluded its 35th Annual General Meeting on September 29, 2026. Key ordinary business transacted included adopting the audited financial statements for FY26 and approving the re-appointment of director Praveen J. Bafna. Special resolutions included appointing Vimal D. Shah as Managing Director, increasing borrowing limits, authorizing the sale or disposal of company undertakings, and enhancing Section 186 limits. Voting results will be disclosed within two working days. Source: BSE